# Locomotion and end-effector pose tracking on Simulation Environment Partial Weakening k\_tau=0.1

Source: [Locomotion and end-effector pose tracking on Simulation Environment Partial Weakening k\_tau=0.1](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-partial-weakening-k_tau-0-1>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2026-06-24T08:29:43.138Z

Evaluation of locomotion and end-effector pose tracking performance within the 'Simulation Environment Partial Weakening k\_tau=0.1' setup, reporting survival rate and reachable workspace.

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

| Scope | Recorded value |
| --- | --- |
| Task | Locomotion and end-effector pose tracking |
| Dataset (including any stated split) | Simulation Environment Partial Weakening k\_tau=0.1 |
| Metric | Survival Rate |
| Unit | PERCENT |
| Direction | Higher is better |
| Results loaded | 26 of 26 |
| Coverage | All results currently returned for this benchmark |

Evaluation settings may differ between results. The original papers and recorded configurations are needed to establish comparability. A shared metric name alone does not establish an identical protocol.

## Metrics

- [Survival Rate](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-partial-weakening-k_tau-0-1.md?metric=Survival%20Rate>): Higher is better; unit: PERCENT.

- [Workspace Volume (m^3)](<https://www.sota2.com/research/sota/locomotion-and-end-effector-pose-tracking-on-simulation-environment-partial-weakening-k_tau-0-1.md?metric=Workspace%20Volume%20(m%5E3)>): Higher is better; unit: SIZE.

## Recorded results

| Method | Survival Rate | Result date | Report paper |
| --- | --- | --- | --- |
| w/o PAM | 96.5 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 96.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 95.6 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 94.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 94.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 93.6 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 93.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 91.8 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 91.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 90.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 86.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| FT-WBC | 84.5 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 83.6 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o PAM | 81.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 79.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 75.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 71.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 68.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 67.7 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 63.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 59.4 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 57.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| w/o FE | 55.2 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 55.1 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 52.3 | Not recorded | 6a3b64d5206542251d7c98ff |
| Robo-Duet | 37.5 | Not recorded | 6a3b64d5206542251d7c98ff |

### w/o PAM

Survival Rate: 96.5. Result ID: 6a3b956dfbc373592c4499ba.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 96.2. Result ID: 6a3b956dfbc373592c4499bb.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 95.6. Result ID: 6a3b956dfbc373592c4499b7.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 94.8. Result ID: 6a3b956dfbc373592c4499b3.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 94.8. Result ID: 6a3b956dfbc373592c4499b6.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 93.6. Result ID: 6a3b956dfbc373592c4499b2.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 93.4. Result ID: 6a3b956dfbc373592c4499af.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 91.8. Result ID: 6a3b956dfbc373592c4499bf.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 91.2. Result ID: 6a3b956dfbc373592c4499ae.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 90.2. Result ID: 6a3b956dfbc373592c4499be.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 86.2. Result ID: 6a3b956dfbc373592c4499ab.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### FT-WBC

Survival Rate: 84.5. Result ID: 6a3b956dfbc373592c4499a8.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 83.6. Result ID: 6a3b956dfbc373592c4499aa.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### w/o PAM

Survival Rate: 81.4. Result ID: 6a3b956dfbc373592c4499a7.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 79.1. Result ID: 6a3b956dfbc373592c4499b9.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 75.2. Result ID: 6a3b956dfbc373592c4499b5.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 71.3. Result ID: 6a3b956dfbc373592c4499b1.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 68.4. Result ID: 6a3b956dfbc373592c4499ad.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 67.7. Result ID: 6a3b956dfbc373592c4499bd.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 63.2. Result ID: 6a3b956dfbc373592c4499b8.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"RR Hip"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 59.4. Result ID: 6a3b956dfbc373592c4499b4.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Hip"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 57.1. Result ID: 6a3b956dfbc373592c4499a9.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Calf"}. This record does not assert independent reproduction.

### w/o FE

Survival Rate: 55.2. Result ID: 6a3b956dfbc373592c4499a6.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

Recorded evaluation configuration: {"Faulty Joint":"FL Calf"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 55.1. Result ID: 6a3b956dfbc373592c4499b0.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"RL Thigh"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 52.3. Result ID: 6a3b956dfbc373592c4499ac.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"FR Thigh"}. This record does not assert independent reproduction.

### Robo-Duet

Survival Rate: 37.5. Result ID: 6a3b956dfbc373592c4499bc.

[Reporting paper](<https://www.sota2.com/research/paper/6a3b64d5206542251d7c98ff.md>)

[Method origin paper](<https://www.sota2.com/research/paper/68fa76ea1e209131cea6fe99.md>)

Recorded evaluation configuration: {"Faulty Joint":"Average"}. This record does not assert independent reproduction.

Page 1 of 1. This is an index page, not the full collection.
